The following is a listing of myeloma treatments associated with this tag.
View all treatments in development for myeloma patients around the US.
PVX-410
PVX-410 is a vaccine that can stimulate the immune system to induce a cytotoxic T-lymphocyte response against the four myeloma-specific antigens.
SparkCures Verified Accurate, up-to-date information. Learn more
The following is a listing of treatments in development for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.
The following is a listing of treatments in development for patients with Smoldering Myeloma.
PVX-410
PVX-410 is a vaccine that can stimulate the immune system to induce a cytotoxic T-lymphocyte response against the four myeloma-specific antigens.
SparkCures Verified Accurate, up-to-date information. Learn more
The following is a listing of myeloma clinical trials associated with this tag.
View all active clinical trials around the US.
SparkCures Verified Accurate, up-to-date information. Learn more
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
ELOTUZUMAB + IBERDOMIDE POST ABECMASafety and Efficacy of Elotuzumab, CC-92480, and Dexamethasone in Relapsed/Refractory Myeloma After CD38- a...
ELOTUZUMAB COMBINATION THERAPYThe following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
Safety and Efficacy of Elotuzumab, CC-92480, and Dexamethasone in Relapsed/Refractory Myeloma After CD38- a...
ELOTUZUMAB COMBINATION THERAPYThe following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
ELOTUZUMAB + IBERDOMIDE POST ABECMASafety and Efficacy of Elotuzumab, CC-92480, and Dexamethasone in Relapsed/Refractory Myeloma After CD38- a...
ELOTUZUMAB COMBINATION THERAPYThe following is a listing of myeloma tags that are associated with this tag.
CAR T Cell
CAR T Cell therapy is a new way to treat multiple myeloma using your own immune system to target and destroy cancer cells.
Monoclonal Antibody
Monoclonal antibodies are large, y-shaped, man-made proteins. They are able to target cancer cells by finding and attaching to unique proteins found on the cell's surface.
Vaccine
Cancer vaccines, also called therapeutic vaccines, are a type of immunotherapy. The vaccines work to boost the body's natural defenses to fight cancer.